27.75
Schlusskurs vom Vortag:
$27.70
Offen:
$27.83
24-Stunden-Volumen:
87,185
Relative Volume:
1.55
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.18%
1M Leistung:
-4.48%
6M Leistung:
-1.39%
1J Leistung:
+4.58%
Elevance Health Inc Stock (EELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
404-892-0896
Adresse
1331 SPRING STREET NW, ATLANTA
Compare EELV vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
EELV
Elevance Health Inc
|
27.75 | 0 | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
371.90 | 327.80B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
86.46 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
386.43 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
270.53 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
388.36 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Aktie (EELV) Neueste Nachrichten
BofA raises target for Elevance Health stock from USD 460.00 to USD 480.00 - AD HOC NEWS
Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins - Yahoo Finance
Elevance Health Unveils 2027 Medicare Advantage Plans, Ticker EL - GuruFocus
Elevance Health Announces 2027 Medicare Advantage Plans - TradingView
Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support - Business Wire
Elevance Health previews lower third-quarter earnings for Elevance Health stock - AD HOC NEWS
Elevance Health (ELV) Is Back In The Spotlight, What Is Drawing Attention? - Simply Wall Street
Elevance Health's Quarterly Earnings Preview: What You Need to Know - inkl
Here's Why Invesco (IVZ) is a Strong Value Stock - Zacks Investment Research
Free cash flow per share of Elevance Health, Inc. – HAN:A58 - TradingView
Could Elevance Health (NYSE:ELV) Reset Its Market Story? - kalkinemedia.com
Chutes & Ladders—UnitedHealthcare names president; Joint Commission CEO to retire - Fierce Healthcare
Elevance Health stock heads into the open after a 0.8 percent gain - AD HOC NEWS
Elevance Health stock carries a USD 27 adjusted EPS outlook - AD HOC NEWS
AM Best withdraws ratings of Elevance Health's Hawaii captive - Captive Insurance Times
Elevance Health stock heads into the open after a 0.45 percent drop - AD HOC NEWS
Elevance Health stock gains 2.1 percent on September 22 - AD HOC NEWS
Elevance Health stock heads into the open after a 2.1 percent gain - AD HOC NEWS
Elevance Health stock holds near its yearly high - AD HOC NEWS
How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet - TradingView
Elevance Health (ELV) Slips 0.80% to $410.95 as Shares Trade Between Key LevelsBPI Bull Correction - siam.in
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Elevance Health stock gains as FY 2026 EPS guidance trails consensus - AD HOC NEWS
Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed - Yahoo Finance
Elevance Health stock gains as FY 2026 EPS guidance trails consensus slightly - AD HOC NEWS
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
NY Surgeons Say Elevance Penalty Policy Is Anticompetitive - law360.com
Elevance Health sued again over out-of-network penalty - Modern Healthcare
Can Carelon Drive Elevance Health's Future Earnings Growth? - Eastern Progress
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock forecasts - Yahoo Finance Australia
Why Does Elevance Health (NYSE:ELV) Matter in S&P 500? - Kalkine Media
Elevance leads UBS health benefits survey as employers brace for higher costs (ELV:NYSE) - Seeking Alpha
Can Centene's Medicare Advantage Strategy Unlock Better Margins? - TradingView
BofA Securities Adjusts Elevance Health Price Target to $480 From $460 - Moomoo
Elevance Health stock gains after reaffirmed 2026 earnings guidance - ad-hoc-news.de
Elevance Health Reaffirms 2026 Earnings and Cost Guidance - The Globe and Mail
Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028? - Yahoo Finance
ELV (Elevance Health) 5-Year EBITDA Growth Rate : 5.30% (As of Jun. 2026) - GuruFocus
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Buy Elevance Health Stock For The Margin It Lost? - trefis.com
Elevance Health reaffirms FY26 EPS guidance, shares rise 5% - scanx.trade
Elevance Health stock gains after 2026 earnings guidance is reaffirmed - ad-hoc-news.de
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation - Benzinga
Why is Elevance Health stock surging today? By Investing.com - Investing.com Nigeria
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com South Africa
Elevance Health reaffirms 2026 earnings and benefit expense guidance - Investing.com
Finanzdaten der Elevance Health Inc-Aktie (EELV)
Es liegen keine Finanzdaten für Elevance Health Inc (EELV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):